A follow-up study on the chemotherapy of neurodermatitis with a monoamine oxidase inhibitor.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001294:Attitude to Health; D001835:Body Weight / Q000187:drug effects; D004032:Diet; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009450:Neurodermatitis / Q000188:drug therapy*; D010624:Phenelzine / Q000009:adverse effects / Q000627:therapeutic use*; D011596:Psychomotor Disorders / Q000139:chemically induced; D012893:Sleep Wake Disorders / Q000139:chemically induced
D010624:Phenelzine